A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...

CBSE Class 12 Date Sheet 2024: CBSE Board has revised the date sheet for the upcoming CBSE Class 10 and 12 Board Exams 2024. There have been minor changes in the exam dates released earlier on ...

Class 12 CBSE Board Preparation Tips 2024: The Class 12th Senior secondary board exam by CBSE is one of the most important examinations of a student’s career. CBSE Class 12 board examination is ...

The distribution of HIV drugs in foreign countries by the U.S. has been paused after President Donald Trump ordered a freeze on foreign aid. The cuts by the Trump administration affect the ...

Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related Benefits in People With HIV Dec. 11 ... to Control of Viral Replication and Reservoirs Sep. 12, 2024 — Researchers ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

A move by the Trump administration to freeze funding for the U.S.’s widely heralded international HIV/AIDS program is sowing uncertainty globally and putting countless lives at immediate risk ...

The far-reaching move could disrupt U.S. programs around the world, including a widely lauded effort to combat HIV worldwide that is credited with saving some 25 million lives, U.S. officials warned.

The NHS will automatically test patients for HIV, Hepatitis B and Hepatitis C unless they opt out at almost 90 Accident and Emergency (A&E) units in England, the BBC can reveal. The government is ...

The success of PEPFAR, the US-led global AIDS relief program, has made HIV a manageable condition for millions. However, the Trump administration's foreign aid cuts and temporary waiver for PEPFAR ...